FIELD: medicine; gynecology; dermatovenerology.
SUBSTANCE: invention can be used in antenatal clinics and clinics for the treatment of bacterial vaginosis. An antimicrobial drug to treat bacterial vaginosis and a probiotic are administered together. A pre-selected probiotic for vaginal use capable of maximally increasing the level of adenosine triphosphoric acid production by microorganisms associated with bacterial vaginosis — Gardnerella vaginalis, Mobiluncus spp. and Prevotella bivia is used. Before starting treatment for bacterial vaginosis, a sample of cervicovaginal contents is obtained from the patient; cultures of microorganisms associated with bacterial vaginosis are isolated from the obtained sample using bacteriological methods; pre-obtained metabolites of 4 probiotic strains are sequentially added to the following isolated cultures: 3 strains of Lactobacillus acidophilus isolated from the Laktonorm, Ecofemin, Gynoflor, and one strain of Lactobacillus casei subsp. rhamnosus Lcr35 isolated from Laktozhinal. Then the change in the level of adenosine triphosphoric acid production is assessed.
EFFECT: invention provides highly effective treatment of bacterial vaginosis.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
| METHOD FOR VAGINAL ATROPHY TREATMENT IN WOMEN IN POSTMENOPAUSE CONSIDERING VAGINAL EPITHELIUM AND MICROBIOCENOSIS STATE | 2017 |
|
RU2636619C1 |
| Lactobacillus rhamnosus strain, POSSESSING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY AGAINST PATHOGENIC AND OPPORTUNISTIC VAGINAL MICROFLORA | 2013 |
|
RU2570622C2 |
| MOLDED CARBON SORBENT WITH GLYCOLIC ACID, A METHOD FOR ITS PREPARATION AND A METHOD FOR TREATING BACTERIAL VAGINOSIS | 2020 |
|
RU2751000C1 |
| METHOD FOR ASSESSING MICROBIAL SPECTRUM OF ENDOMETRIUM FOR ETIOLOGIC DIAGNOSIS OF CHRONIC ENDOMETRITIS | 2015 |
|
RU2599479C1 |
| GARDNERELLA VAGINALIS (VARIANTS) STRAINS, POTENTIALLY IMPORTANT FOR BACTERIAL VAGINOSIS DIAGNOSTICS, AND STRAIN INCLUDING COLLECTION THEM FOR BACTERIAL VAGINOSIS DIAGNOSTICS | 2015 |
|
RU2636005C2 |
| TOPICAL DERMAL COMPOSITION CONTAINING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS, AND USING IT | 2010 |
|
RU2536264C2 |
| METHOD FOR BACTERIAL VAGINOSIS TREATMENT OR PREVENTION | 2011 |
|
RU2632110C2 |
| METHOD FOR IDENTIFICATION AND EVALUATIION OF OPPORTUNISTIC INFECTIONS AGENTS PATHOGENICITY LEVEL IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR PREDICTION OF COURSE AND DEVELOPMENT OF INFECTIOUS DISEASES COMPLICATIONS | 2016 |
|
RU2638453C1 |
| METHOD FOR PREDICTION OF RISK OF PRENATAL OUTFLOW OF AMNIOTIC FLUID IN TERM OF FULL-TERM PREGNANCY | 2020 |
|
RU2739123C1 |
